|
Scientific presentation
| 1. |
Feldman L, Barkun J, Barkun A, Sampalis
J, Rosenberg L. Measuring post-operative complications in general
surgery patients using an oitcomes-based strategy: Comparison
with complications presented at morbidity and mortality rounds.
Central Surgical Association, Chicago, 1997 |
| 2. |
Rosenberg L, MacNeil P, Turcotte
L. Economic evaluation of the use of octreotide in prevention
of complications following pancreatic resection. Society for
the Surgery of the Alimentary Tract. Washington, 1997. |
| 3. |
Paraskevas S, Maysinger D, Lakey
JRT, Cavanagh TJ, Wang R, Rosenberg L. Activation of JNK, p38
and ERK in cultured human, canine and porcine islets. International
Pancreas and Islet transplant Association. Milan, 1997. |
| 4. |
Paraskevas S, Maysinger D, Lakey
JRT, Cavanagh TJ, Wang R, Rosenberg L. Modulation of JNK and
p38 MAP kinase activity by insulin in human, porcine and canine
islets.International Pancreas and Islet transplant Association.
Milan, 1997. |
| 5. |
Paraskevas S, Maysinger D, Lakey
JRT, Cavanagh TJ, Rosenberg L. Modulation of JNK and p38 MAP
kinase activity by insulin in human, porcine and canine islets.
Canadian Diabetes Association, Scientific Meeting. London, 1997.
|
| 6. |
Wang R, Rosenberg L. The natural history
of the islet after routine isolation. Canadian Diabetes Association,
Scientific Meeting. Calgary, 1998. |
| 7. |
Rosenberg L, Wang R, Paraskevas S, Maysinger
D. Structural and functional changes resulting from islet isolation
lead to islet cell death. Society of University Surgeons, New
Orleans, 1999. |
| 8. |
Wang RN, Li JM, Rosenberg L. Factors inducing
islet cell transdifferentiation to duct-like epithelial cells.
American Pancreatic Association, Chicago, 1999. |
| 9. |
Paraskevas S, Wang RN, Li J-M, Agapitos
D, Maysinger D, Rosenberg L. Insulin-like growth factors promote
islet cell survival in vitro through MAP kinase mediated signaling.
American Society of Transplant Surgeons, Chicago, 2000. |
| 10. |
Paraskevas S, Wang RN, Li J-M, Agapitos
D, Rosenberg L, Maysinger D. Tacrolimus mediates islet cell
survival in vitro: A role for calcineurin inhibition during
isolation. American Society of Transplant Surgeons, Chicago,
2000. |
| 11. |
Rosenberg L, Wang RN, Li J-M, Pittenger
G, Duguid WP, Vinik AI. INGAP peptide increases ß-cell
mass and insulin content in adult hamsters and reverses STZ
diabetes. American Diabetes Association. San Antonio, 2000. |
| 12. |
Ramaswamy A, Brown RA, Joseph L, Rosenberg
L. Outcome of acute pancreatitis: 41 years of management at
a university hospital. Society for Surgery of the Alimentary
Tract, San Diego, 2000. |
| 13. |
Fujisato T, Rosenberg L. Development of
artificially vascularized tissue scaffolds for islet cell transplantation.
Sixth World Biomaterials Congress. Kamuela, Hawaii, 2000. |
| 14. |
Wang RN and Rosenberg L. Factors mediating
the transformation of islets of Langerhans to duct epithelial-like
structures. Annual meeting of the CDA/CSEM Profesional Conference,
Edmonton, Alberta 2001. |
| 15. |
Hazrati A and Rosenberg L. The role of TGF-ß
in pancreatic islet transdifferentiation. 6th International
Congress of Endocrinology, Teheran, Iran, 2001. |
| 16. |
Petropavlovskaia M, Rosenberg L. Identification
and characterization of “small cells” in pancreas.
NIH Workshop on Pancreatic Development, Bethesda, 2001. |
| 17. |
Wissal E-A, Buteau J, Roduit R, Peyot M-L, Hardy
S, Joly E, Ghassan D, Rosenberg L, Prentki M. Elevated glucose
and saturated fatty acids synergize in causing pancreatic ß-cell
death. A.D.A., San Francisco, 2002. |
| 18. |
Taylor-Fishwick D, Kendall HM, Ray MK, Roy L,
Cao Y, Pittenger GL, Rosenberg L, Vinik AI. Induction of INGAP
expression through an activation of protein kinase C and cytokine-induced
STAT-signaling. A.D.A., San Francisco, 2002. |
| 19. |
Hazrati A, Jamal A-M, Rosenberg L. The role of
transforming growth factor-ß in the transdifferentiation
of islets of Langerhans to duct-like epithelial structures.
A.D.A., San Francisco, 2002. |
| 20. |
Jamal A-M, Lipsett M, Hazrati A, Maysinger D,
Pittenger GL, Taylor-Fishwick D, Vinik AI, Rosenberg L. INGAP
peptide induces in vitro islet cell neogenesis from human duct-like
islet progenitor cells. Endocrine Society, San Francisco, 2002. |
| 21. |
Pittenger GL, Fishwick-Taylor D, Kosuri S, Burcus
NL, Rosenberg L, Vinik AI. INGAP peptide- an initiator of neuroendocrine
cell (PGP9.5) development and islet transdifferentiation/transcription
factor (Pdx-1) expression in normal dog pancreas. Endocrine
Society, San Francisco, 2002. |
| 22. |
Hazrati A, Jamal A-M, Rosenberg L. The role of
transforming growth factor-ß in the transdifferentiation
of islets of Langerhans to duct-like epithelial structures.
Stem Cell Network of Canada, Toronto, 2002. |
| 23. |
Jamal A-M, Lipsett M, Hazrati A, Rosenberg L.
INGAP peptide induces islet cell neogenesis from human pancreatic
progenitor. Stem Cell Network of Canada, Toronto, 2002. |
| 24. |
Lipsett M, Jamal A.M., Rosenberg L. Acinar cell
plasticity: An alternate pathway to ß-cell neogenesis.
Stem Cell Network of Canada, Toronto, 2002. |
| 25. |
Petropavlovskaia M, Rosenberg L. Identification
and characterization of putative islet cell progenitors. Stem
Cell Network of Canada, Toronto, 2002. |
| 26. |
Tam J, Rosenberg L, and Maysinger D. Islet-neogenesis
associated protein enhances neurite outgrowth from DRG neurons.
IUPHAR XIVth World Congress of Pharmacology, San Francisco,
July 2002. |
| 27. |
Aikin R, Maysinger D, Rosenberg L. Inhibition
of apoptosis in isolated islets of Langerhans leads to increased
levels of caspase-dependent cell death. APOPTOSIS 2003, Luxembourg,
2003. |
| 28. |
Wang G-S, Fieldus WE, Pulido O, Rosenberg L,
Scott FW. Neonatal insulitis, nestin expression and diet-modifiable
changes in islet homeostasis. ADA, New Orleans, 2003. |
| 29. |
Lipsett M, Hanley S, Radzioch D, Finegood D, Compton
C, Scott F and Rosenberg L. Identification and inhibition of
islet cell neogenesis using an anti-INGAP polyclonal antibody.
ADA, New Orleans, 2003. |
| 30. |
Lipsett M, Hanley S, Jamal A-M and Rosenberg L.
Development of a novel in vitro model to study acinar-to-islet
differentiation. ADA, New Orleans, 2003 |
| 31. |
El-Assaad W, Joly E, Buteau J, Sladek R, Hudson
T, Rosenberg L, Prentki M. Novel insights into the biochemical
basis of pancreatic ß-cell glucolipotoxicity. ADA, New
Orleans, 2003. |
| 32. |
Buteau J, El-Assaad W, Rhodes CJ, Rosenberg L,
Joly E and Prentki M. Glucagon-Like Peptide-1 Prevents ß-Cell
Glucolipotoxicity in Human Islets and INS832/13 Cells. ADA,
New Orleans, 2003. |
|
